1Asgharian B, Chen YJ, Patronas NJ, etal. Meningiomas may be a component tumor of multiple endocrine neoplasia type 1. Clin. Cancer Res, 2004,10(3) :869-880.
2Palmer JD Sparrow OC lannotti F, et al. Postoperative hematoma: a 5-year survey and identification of avoidable risk factors. Neurosurgery, 1994, 35(6): 1061-1064.
3Gerlach R, Raabe A, Scharrer I et al. Post-operative hematoma after surgery for intracranial meningiomas: causes, avoidable risk factors and clinical outcome. Neurol Res, 2004, 26(1):61-66.
4Fujii Y, Tanaka R, Takeuchi S, ,et al. Serial changes in hemostasis after intracranial surgery. Neurosurgery, 1994, 35(1):26-33.
5Abrahams JM, Torchia MB, McGarvey M, et al. Perioperative assessment of coagulability in neurosurgical patients using thromboelastography. Surg Neurol, 2002, 58(1):5-11.
6Vukovich TC, Gabriel A, Schaeffer B, et al. Hem ostasis activation in patients undergoing brain tumor surgery. J Neurosurg, 1997, 87 (4): 508-511.
7Dragoni F, Mazzucconi MG, Acqui M, et al. Coagulation study in patients who had undergone surgery for meningioma. Haemostasis, 1993, 23(6):301-307.
8Heesen M, Kemkes-Matthes B, Deinsberger W, et al. Coagulation alterations in patients undergoing elective craniotomy. Surg Neurol, 1997, 47(1):35-38.
9Kearney TJ, Bentt L Grode M, et al. Coagulopathy and catecholamines in severe head injury. J Trauma, 1992, 32(5) :608-611
10Manelfe C, Guiraud B, David J, et al. Embolization by catheterization of intracranial meningiomas. Rv Neurol, 1973,128:339-351.
